Sign in
4

Changes in Ownership

Kura Oncology, Inc. Filed Acc 0001209191-19-039245

Options or other derivatives

  • Director acquired 13,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Szela Mary T · Director

Table II: Derivative

1 line
Date Transaction Shares Exercise Expires Underlying Owned after D/I
2019-06-25 Grant or award : show line 1 in the form Option to purchase common stock +13,000 $19.55 2029-06-24 13,000 13,000 D
Loading xslF345X03/doc4.xml…